Nasdaq Grants ASPAC III Extension to November 12, 2026 to Regain Compliance
ASPC is trading near its 52-week low of $10.11 (4.8% above the low) on light trading volume (0.2× avg).
Summary
ASPAC III Acquisition Corp. received Nasdaq's acceptance of its compliance plan, extending the deadline to November 12, 2026 to regain compliance with the minimum stockholders' equity requirement. The company plans to regain compliance through its proposed merger with Bioserica.
Key Events · Legal and Risk Events · ASPC
-
Nasdaq Compliance Plan Accepted
On July 17, 2026, Nasdaq accepted the company's compliance plan, granting an extension until November 12, 2026 to regain compliance with Rule 5550(b).
-
Compliance Plan Relies on Bioserica Merger
The plan proposes that the Bioserica merger will result in PubCo meeting the $75 million market value standard for Nasdaq Global Market listing under Rule 5405(b)(3).
-
Going Concern Warning Reiterated
Management reiterates substantial doubt about the company's ability to continue as a going concern, citing the mandatory liquidation if a business combination is not completed by November 12, 2026.
-
Cash Position Deteriorating
Cash decreased to $633,724 as of June 30, 2026, from $871,350 at December 31, 2025, with working capital of $237,744.
Analysis · ASPC · Real Estate & Construction
Nasdaq's acceptance of the compliance plan extends the deadline to November 12, 2026, a critical reprieve given the delisting threat. The proposed Bioserica merger offers a path back to compliance, but substantial doubt remains about the company's ability to complete the deal and meet listing requirements, with the stock trading near its 52-week low.
At the time of this filing, ASPC was trading at $10.60 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $24.8M. The 52-week trading range was $10.11 to $63.98. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.